Our observations revealed a significant increase in CD25, CD69, and CD62L expression in LPS-RGD-Nb36-DOX as well as DC/tumor fusion vaccine-activated CD8+ T cells (P < 0.001) (Fig. 2B). The gene discussed is CD8A; the disease is neoplasm.